Werewolf Therapeutics, Inc. - Common Stock, $0.0001 par value per share (HOWL)

CUSIP: 95075A107

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+3,787,065
Put/Call ratio
2.7%
SEC-reported price per share
$3.86
Number of holders
41
Value change
+$14,923,168
Number of buys
23
Open additional details 1 more signal available
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
48,427,829

Security key

95075A107

Report period

Q4 2023

Institutions

41

Top holders

10

Ownership snapshot

Top reported holders of HOWL - Werewolf Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 13%
MPM ASSET MANAGEMENT LLC 8.8%
PFM Health Sciences, LP 5.3%
MPM BioImpact LLC 4.9%
Rubric Capital Management LP 4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
13%
$13,150,045
6,144,881 shares
30 Sep 2023
MPM ASSET MANAGEMENT LLC
13F
Company
13F
8.8%
$9,168,128
4,284,172 shares
30 Sep 2023
PFM Health Sciences, LP
13F
Company
13F
5.3%
$5,474,723
2,558,282 shares
30 Sep 2023
MPM BioImpact LLC
13F
Company
13F
4.9%
$5,110,344
2,388,011 shares
30 Sep 2023
Rubric Capital Management LP
13F
Company
13F
4%
$4,141,664
1,935,357 shares
30 Sep 2023
BANK OF AMERICA CORP /DE/
13F
Company
13F
3.2%
$3,278,318
1,531,924 shares
30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
41
Shares
27,669,999
Rows available
41
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
34
Q4 2023 holders
41
Holder diff
7
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .